GlaxoSmithKline (Suzhou) Co., Ltd.
GlaxoSmithKline (Suzhou) Co.,Ltd, is a wholly-owned subsidiary of the world’s leading pharmaceutical company in the United Kingdom, and is located in the Luzhi Industrial Park, which belongs to Wujiang District, in Suzhou.
Since its establishment in 2008, GlaxoSmithKline (Suzhou) Co.,Ltd. has been committed to promoting the public health in Suzi by providing innovative treatments and prevent disease.
It mainly focuses on three major therapeutic areas: respiratory, anti-viral and metabolic diseases, aiming to accelerate the development of new human medications in China.
With the introduction of the latest products, R&D capabilities and production management processes, GlaxoSmithKline (Suzhou) Co.,Ltd. has advanced to a new level of pharmaceutical production and is widely recognized internationally by the industry. The Company has been awarded the advanced level of hygienic standard for the production and processing conditions of medicines in accordance with the Good Manufacturing Practice.
In recent years, GlaxoSmithKline (Suzhou) Co.,Ltd. has focused on driving integrated business healthy, launching new products and improving core services related to healthcare and health reform. We are also fully committed to developing innovative pharmaceuticals with an eye on global trends.
We have an experienced and passionate team, focusing on innovation and new drug research. To promote medical and public health development in China, the company continues to increase R&D investment, and works closely with the Chinese governments and customers to provide innovative drugs and well-rounded services to meet the diverse needs of patients and provide them with the most appropriate and cost-effective treatments.
Since its establishment, GlaxoSmithKline (Suzhou) Co.,Ltd. has always been devoted to improving patient health, providing health services and developing new treatments that are safe and effective. Through this, we hope to build a better future for the people of Suzhou.
We strive to achieve better medical and public health outcomes through innovation and partnership. Guided by our focus on patient need, we provide high quality products and services that are more beneficial to health and improve the well-being of people in Suzhou.
We look forward to a future of collaboration and innovation that brings tangible benefits to patients, healthcare professionals and the entire healthcare system.
